Articles From: Solazyme Receives FDA GRAS No Questions Letter for New Vegan Protein Source, Whole Algal Protein to Sonic Automotive Mourns The Loss Of Robert L. Rewey, Long-Time Director


2015/1/15
Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and ingredients company, is pleased to announce that the US Food and Drug Administration (FDA) has issued a favorable response to Solazyme’s notification concluding that Whole Algal Protein is Generally Recognized as Safe (GRAS) as an ingredient in food and beverage products.
Sign-up for Solazyme Receives FDA GRAS No Questions Letter for New Vegan Protein Source, Whole Algal Protein investment picks
2015/2/26
Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the fourth quarter and full year ended December 31, 2014.
Sign-up for Solazyme Reports Fourth Quarter and Full Year 2014 Results investment picks
2015/2/12
Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and ingredients company, today announced it will host a conference call and webcast on Thursday, February 26, 2015 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2014 financial results.
Sign-up for Solazyme to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015 investment picks
2015/1/12
The AN/PRC-155 radios also achieved satellite communications milestones using the new Mobile User Objective System.
Sign-up for Soldier's Network Update: Another 1,200 AN/PRC-155 Radios by General Dynamics and Rockwell Collins to Provide Vital Communications 'Connecting Points' for U.S. Army Soldiers investment picks
2014/12/15
Acquisition Adds to Solera's Risk and Asset Management Portfolio WESTLAKE, Texas , Dec.
Sign-up for Solera Holdings, Inc. Announces Acquisition of IBS Automotive s.r.o, a Leading Provider of Vehicle Valuation Data in the Czech Republic and Slovakia investment picks
2015/2/5
Second Quarter Revenues of $282.7 Million, up 18.3% on a Reported Basis and up 23.8% on a Constant Currency Basis; Adjusted EBITDA up 15.0% on a Reported Basis and up 21.8% on a Constant Currency Basis; Company Updates Guidance and Announces Quarterly Dividend WESTLAKE, Texas , Feb.
Sign-up for Solera Holdings, Inc. Reports Second Quarter 2015 Results investment picks
2015/1/26
WESTLAKE, Texas , Jan.
Sign-up for Solera Holdings, Inc. Schedules Second Quarter Fiscal 2015 Earnings Announcement and Conference Call investment picks
2015/2/25
Partnership intended to enable rapid deployment, reliable delivery and improved experiences for today's developers and online gamers CAMBRIDGE, Mass.
Sign-up for Solid State Networks, Akamai Partner to Create Workflow for Developing, Launching and Managing Online Games investment picks
2015/2/11
By Dominic Chopping Finnish state-owned investment company Solidium Oy said Wednesday it has placed 200 million shares in TeliaSonera AB (TLSN.SK), representing 4.6% of the outstanding share capital, in an accelerated bookbuilt offering to institutional investors at SEK51.00 a share.
Sign-up for Solidium Places 200 Million Shares in Teliasonera at SEK51/Share investment picks
2015/1/5
PRINCETON, N.J. , Jan.
Sign-up for Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome investment picks
2014/12/29
PRINCETON, N.J. , Dec.
Sign-up for Soligenix Announces Publication of Combination Ricin/Anthrax Vaccine Data investment picks
2015/1/29
PRINCETON, N.J. , Jan.
Sign-up for Soligenix Announces Publication Successfully Demonstrating Enhanced Immunogenicity of its Heat-Stable Anthrax Vaccine investment picks
2015/2/5
Presentation to be Webcast Live on February 10, 2015 at 1:30 PM EST PRINCETON, N.J. , Feb.
Sign-up for Soligenix to Present at the 17th Annual BIO CEO & Investor Conference in New York City investment picks
2014/12/10
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris ® (eculizumab) has been granted orphan drug designation (ODD) by Japan’s Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myasthenia gravis (MG), a rare, debilitating neurologic disorder.
Sign-up for Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis investment picks
2015/1/14
Solitario Exploration & Royalty Corp.
Sign-up for Solitario Announces Mt. Hamilton Reclamation Permits Approved investment picks
2015/2/3
Solitario Exploration & Royalty Corp.
Sign-up for Solitario Options Its Norcan Copper Project in Mexico investment picks
2015/2/19
Solium Announces Appointment of Marcos Lopez as Chief Executive Officer Canada NewsWire CALGARY , Feb.
Sign-up for Solium Announces Appointment of Marcos Lopez as Chief Executive Officer investment picks
2015/2/26
Solium to Host Fourth Quarter 2014 Investor Conference Call on Tuesday, March 17, 2015 at 5:30 P.M. (EST) Canada NewsWire CALGARY , Feb.
Sign-up for Solium to Host Fourth Quarter 2014 Investor Conference Call on Tuesday, March 17, 2015 at 5:30 P.M. (EST) investment picks
2015/1/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1169997&ProfileId=051205&sourceType=1 OMAHA, NE --
Sign-up for Solutionary Appoints New CIO; Executive Vice President, Corporate Development; and Vice President, Customer Experience investment picks
2015/2/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174102&ProfileId=051205&sourceType=1 OMAHA, NE --
Sign-up for Solutionary Launches Targeted Threat Intelligence Service to Increase Situational Awareness and Mitigate Attacks for Enterprises investment picks
2015/1/26
Solutionstar Holdings LLC, an indirect wholly-owned subsidiary of Nationstar Mortgage Holdings Inc. (NYSE: NSM) (“Nationstar”), announced today that it has closed the acquisition of Experience 1, Inc., the holding company for Title365, Trusted Signing and technology subsidiaries X1 Labs and X1 Xpress (collectively, “Title365”). This acquisition is another strategic move to leverage technological expertise to deliver comprehensive, end-to-end online services for homebuyers, home sellers and real estate professionals.
Sign-up for Solutionstar Announces Closing of Title365 Acquisition investment picks
2015/2/5
Women's Retailer Launches Its First Annual Campaign to Raise Awareness for the American Heart Association NEW YORK , Feb.
Sign-up for Soma Announces Its Touch A Heart Campaign to Support the American Heart Association investment picks
2015/1/8
Intimate Apparel Retailer Asks Women to Open Their Top Drawers and Their Hearts to Help Women in Need NEW YORK , Jan.
Sign-up for Soma Builds Domestic Violence Awareness With Bi-Annual Giving is Beautiful™ Soma Bra Donation investment picks
2014/12/15
http://media3.marketwire.com/logos/20131105-Sonde.jpg CALGARY, ALBERTA --
Sign-up for Sonde Resources Corp. Executes Exclusivity Agreement and Pays Exploratory Well Penalty investment picks
2014/12/29
Curated Streaming Music Experiences Now Available to Millions of Songza Subscribers Via Play-Fi Whole Home Audio Technology CALABASAS, Calif.
Sign-up for Songza Now Available on DTS Play-Fi® Ecosystem investment picks
2015/1/6
Sonic Corp.
Sign-up for Sonic Achieves Strong First Quarter Results investment picks
2014/12/3
CHARLOTTE, N.C. , Dec.
Sign-up for Sonic Automotive Mourns The Loss Of Robert L. Rewey, Long-Time Director investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Solazyme Receives FDA GRAS No Questions Letter for New Vegan Protein Source, Whole Algal Protein to Sonic Automotive Mourns The Loss Of Robert L. Rewey, Long-Time Director
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent